Targeting the pathophysiology of diabetic macular edema.
作者信息
Romero-Aroca Pedro
出版信息
Diabetes Care. 2010 Nov;33(11):2484-5. doi: 10.2337/dc10-1580.
Abstract
摘要
相似文献
1
Targeting the pathophysiology of diabetic macular edema.针对糖尿病性黄斑水肿的病理生理学。
Diabetes Care. 2010 Nov;33(11):2484-5. doi: 10.2337/dc10-1580.
2
Anti-VEGF therapeutic approaches for diabetic macular edema.用于治疗糖尿病性黄斑水肿的抗血管内皮生长因子治疗方法。
Int Ophthalmol Clin. 2009 Spring;49(2):109-19. doi: 10.1097/IIO.0b013e31819fd8b5.
3
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.雷珠单抗治疗糖尿病黄斑水肿的安全性和有效性（RESOLVE 研究）：一项为期 12 个月、随机、对照、双盲、多中心的 II 期研究。
Diabetes Care. 2010 Nov;33(11):2399-405. doi: 10.2337/dc10-0493.
4
In vision trial, some researchers would rather see double.
Nat Med. 2010 Jun;16(6):611. doi: 10.1038/nm0610-611.
5
[Avastin a treatment of diabetic macular edema].
Oftalmologia. 2011;55(1):63-7.
6
Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection.
Eye (Lond). 2009 May;23(5):1229. doi: 10.1038/eye.2008.162. Epub 2008 Jun 6.
7
Ranibizumab for diabetic macular edema.
Ophthalmology. 2013 Jan;120(1):221. doi: 10.1016/j.ophtha.2012.07.069.
8
Ranibizumab for diabetic macular edema. Author reply.
Ophthalmology. 2013 Jan;120(1):221-2. doi: 10.1016/j.ophtha.2012.07.070.
9
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.随机试验评估雷珠单抗联合即刻或延迟激光或曲安奈德联合即刻激光治疗糖尿病黄斑水肿。
Ophthalmology. 2010 Jun;117(6):1064-1077.e35. doi: 10.1016/j.ophtha.2010.02.031. Epub 2010 Apr 28.
10
Revolution to a new standard treatment of diabetic macular edema.糖尿病性黄斑水肿的治疗迎来新标准变革。
JAMA. 2014 Jun 11;311(22):2269-70. doi: 10.1001/jama.2014.2536.
引用本文的文献
1
The Impact of the Foveal Bulge on Visual Acuity in Resolved Diabetic Macular Edema and Retinal Vein Occlusions.黄斑隆起对已消退的糖尿病性黄斑水肿和视网膜静脉阻塞患者视力的影响。
Cureus. 2024 Dec 11;16(12):e75543. doi: 10.7759/cureus.75543. eCollection 2024 Dec.
2
Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema.地塞米松玻璃体内植入物对糖尿病性黄斑水肿多焦视网膜电图的影响
Drug Des Devel Ther. 2024 Nov 25;18:5367-5375. doi: 10.2147/DDDT.S477677. eCollection 2024.
3
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.法西单抗治疗新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿：从临床前研究到 3 期结果。
Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3437-3451. doi: 10.1007/s00417-024-06531-9. Epub 2024 Jun 7.
4
Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study.影响糖尿病性黄斑水肿密集型阿柏西普治疗反应的因素：一项真实世界研究。
J Diabetes Res. 2023 Jul 18;2023:1485059. doi: 10.1155/2023/1485059. eCollection 2023.
5
Preliminary Report on Optical Coherence Tomography Angiography Biomarkers in Non-Responders and Responders to Intravitreal Anti-VEGF Injection for Diabetic Macular Oedema.玻璃体内抗VEGF注射治疗糖尿病性黄斑水肿无反应者和有反应者的光学相干断层扫描血管造影生物标志物初步报告
Diagnostics (Basel). 2023 May 13;13(10):1735. doi: 10.3390/diagnostics13101735.
6
Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases.考虑在视网膜疾病治疗中使用光生物调节疗法。
Biomolecules. 2022 Dec 3;12(12):1811. doi: 10.3390/biom12121811.
7
Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy.糖尿病黄斑水肿和增生性糖尿病视网膜病变的新疗法。
Curr Diab Rep. 2021 Nov 1;21(10):43. doi: 10.1007/s11892-021-01412-5.
8
Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study.椭球区完整性和糖尿病性黄斑水肿治疗期间视力变化的纵向研究。
J Diabetes Res. 2021 Oct 7;2021:8117650. doi: 10.1155/2021/8117650. eCollection 2021.
9
Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization.《累及黄斑中心凹的糖尿病性黄斑水肿管理指南：治疗选择与患者监测》
Clin Ophthalmol. 2021 Jul 30;15:3221-3230. doi: 10.2147/OPTH.S318026. eCollection 2021.
10
Kidney Diseases: The Age of Molecular Markers.肾脏病学：分子标志物的时代。
Adv Exp Med Biol. 2021;1306:13-27. doi: 10.1007/978-3-030-63908-2_2.
本文引用的文献
1
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.雷珠单抗治疗糖尿病黄斑水肿的安全性和有效性（RESOLVE 研究）：一项为期 12 个月、随机、对照、双盲、多中心的 II 期研究。
Diabetes Care. 2010 Nov;33(11):2399-405. doi: 10.2337/dc10-0493.
2
Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.1 型糖尿病患者强化治疗对 DCCT/EDIC 研究中视网膜病变 10 年进展的影响：成人与青少年的比较。
Diabetes. 2010 May;59(5):1244-53. doi: 10.2337/db09-1216. Epub 2010 Feb 11.
3
Diabetic macular edema: pathogenesis and treatment.糖尿病性黄斑水肿：发病机制与治疗
Surv Ophthalmol. 2009 Jan-Feb;54(1):1-32. doi: 10.1016/j.survophthal.2008.10.001.
4
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.一项比较玻璃体内注射曲安奈德与局部/格栅光凝治疗糖尿病性黄斑水肿的随机试验。
Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.
5
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.一项关于抗血管内皮生长因子适体培加他尼治疗糖尿病性黄斑水肿的II期随机双盲试验。
Ophthalmology. 2005 Oct;112(10):1747-57. doi: 10.1016/j.ophtha.2005.06.007.
6
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.威斯康星糖尿病性视网膜病变流行病学研究。第十五部分。黄斑水肿的长期发病率。
Ophthalmology. 1995 Jan;102(1):7-16. doi: 10.1016/s0161-6420(95)31052-4.
7
Diabetic maculopathy. A critical review highlighting diffuse macular edema.糖尿病性黄斑病变。一篇重点论述弥漫性黄斑水肿的批判性综述。
Ophthalmology. 1983 Nov;90(11):1301-17. doi: 10.1016/s0161-6420(83)34388-8.
Zotero 插件